Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/21/1994 | WO1994015635A1 Inducing cytotoxic t lymphocyte responses |
07/21/1994 | WO1994015624A1 Use of sulphated polysaccharides for preventing sexually transmitted diseases |
07/21/1994 | WO1994015619A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH |
07/21/1994 | WO1994015614A1 Antiviral topical pharmaceutical compositions |
07/21/1994 | WO1994015591A1 Onychomycosis remedy composition |
07/21/1994 | WO1994015585A1 Human immunodeficiency virus decoy |
07/21/1994 | WO1994007479A3 Immunopotentiatory agents |
07/21/1994 | DE4400659A1 Prodn. of viral membrane protein domains |
07/21/1994 | CA2153987A1 Amino acids and peptides having modified terminals |
07/21/1994 | CA2152915A1 Antibodies directed against binding-associated epitopes |
07/21/1994 | CA2152672A1 Oligomers having improved stability at acid ph |
07/21/1994 | CA2152509A1 Method to predict active growth of bacteria adhered to a surface |
07/21/1994 | CA2152490A1 Human immunodeficiency virus decoy |
07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |
07/20/1994 | EP0606869A1 Promotor sequence of the p55 tumor necrosis factor receptor |
07/20/1994 | EP0606506A1 Beta-lactamase resistant antibacterial composition |
07/20/1994 | EP0606452A1 Vector vaccines of recombinant feline herpesvirus |
07/20/1994 | EP0606437A1 Non-shedding live herpesvirus vaccine |
07/20/1994 | EP0606382A1 1,8-benzonaphthyridine derivatives and antimicrobial compositions |
07/20/1994 | EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
07/20/1994 | EP0484406B1 Polypeptide inhibitor of viral replication |
07/20/1994 | EP0417105B1 Topically applied gold organic complex |
07/20/1994 | EP0414806B1 High ratio active agent:lipid complex |
07/20/1994 | EP0378641B1 Novel antimicrobial peptide, compositions containing same and uses thereof |
07/20/1994 | CN1089505A Novel pharmaceutical application of nonimmunogenproteinic material and composition |
07/20/1994 | CN1089478A Therapeutic agent and its use |
07/20/1994 | CN1025500C Process for prepn. of heteroaryl 3-oxo-propanenitrile derivatives |
07/20/1994 | CA2113513A1 Quinolone- und naphthyridonecarboxylic acid derivatives |
07/19/1994 | US5330975 Bacterial toxin neutralizer |
07/19/1994 | US5330973 Lipopeptide derivatives |
07/19/1994 | US5330754 Membrane-associated immunogens of mycobacteria |
07/19/1994 | CA1330794C Anti-viral compounds, dosage forms and methods |
07/19/1994 | CA1330759C Method for the treatment of gastro intestinal disorders |
07/13/1994 | EP0606062A1 9-Deoxo-9a-aza-11-deoxy-9a-homoerythromycin A 9a,11-cyclic carbamates |
07/13/1994 | EP0606046A1 Arylsulfonamido-substituted hydroxamic acids |
07/13/1994 | EP0606024A1 Erythromycin derivatives, their process of preparation and their application as medicaments |
07/13/1994 | EP0605836A1 Cephalosporin derivatives |
07/13/1994 | EP0605704A1 Starch-iodine-peroxide preservation of blood, tissues and biological fluids |
07/13/1994 | EP0605700A1 Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
07/13/1994 | EP0605690A1 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids |
07/13/1994 | EP0605680A1 Infectious bovine rhinotracheitis virus mutants and vaccines |
07/13/1994 | EP0605524A1 Antibacterial, antimycoplasmal compounds related to mupirocin |
07/13/1994 | EP0605466A1 Method and compositions for cellular reprogramming |
07/13/1994 | EP0605432A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
07/13/1994 | EP0327640B1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome |
07/13/1994 | EP0309483B1 Production and use of anthelmintic agents and protective antigens |
07/13/1994 | CN1089267A Chemical compounds |
07/12/1994 | US5328908 Antimicrobial quinolone thioureas |
07/12/1994 | US5328904 Active against methicillin resistant Staphylococcus |
07/12/1994 | US5328902 Antibiotics |
07/12/1994 | US5328688 Recombinant herpes simplex viruses vaccines and methods |
07/12/1994 | US5328470 Catheter |
07/07/1994 | WO1994014962A1 Vaccines against varicella-zoster virus (vzv) |
07/07/1994 | WO1994014961A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
07/07/1994 | WO1994014956A1 Molecular flashlight |
07/07/1994 | WO1994014838A1 Antibiotics ge 37468 a, b and c |
07/07/1994 | WO1994014818A1 Cephem compounds with antimicrobial activity |
07/07/1994 | WO1994014811A1 2-(2-substituted pyrrolidin-4-yl)thio-carbapenem derivatives |
07/07/1994 | WO1994014802A1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
07/07/1994 | WO1994014798A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors |
07/07/1994 | WO1994014793A1 Cyclic sulfone containing retroviral protease inhibitors |
07/07/1994 | WO1994014789A1 Coumarin derivatives as retroviral inhibitors |
07/07/1994 | WO1994014473A1 Therapeutic combination containing interferon |
07/07/1994 | WO1994014456A1 Use of dideoxy nucleoside analogues in the treatment of viral infections |
07/07/1994 | WO1994014448A1 Novel combination of benzoquinazoline antifolates and protecting agents |
07/07/1994 | WO1994014437A1 Prevention and treatment of sepsis |
07/07/1994 | WO1994014436A1 Retroviral protease inhibiting compounds |
07/07/1994 | WO1994014347A1 A protective garment |
07/07/1994 | WO1994010317A3 Conjugate vaccine against group b streptococcus |
07/07/1994 | CA2153069A1 Cyclic sulfone moiety-containing hydroxyethylamine retroviral protease inhibitors |
07/07/1994 | CA2152389A1 Therapeutic combination containing interferon |
07/07/1994 | CA2152256A1 Vaccines against varicella-zoster virus (vzv) |
07/07/1994 | CA2151616A1 Antibiotics ge 37468 a, b and c |
07/07/1994 | CA2151386A1 Prevention and treatment of sepsis |
07/06/1994 | EP0605031A1 Phenoxy- and phenoxyalkyl-piperidines as antiviral agents |
07/06/1994 | EP0604920A1 Novel cephalosporin compounds |
07/06/1994 | EP0604744A2 Method for treating systemic inflammatory response syndrome |
07/06/1994 | EP0604566A1 Chimeric and/or growth-restricted flaviviruses |
07/06/1994 | EP0604488A1 Polypeptides, inhibitors of the replication of hsu and similar viruses |
07/06/1994 | EP0604409A1 Compositions and methods for detecting and modulating rna activity and gene expression |
07/06/1994 | EP0524961B1 Azo-derivatives, pharmaceutical preparations containing them, and their use against aids |
07/06/1994 | EP0342203B1 2',3' dideoxyribofuranoxide derivatives |
07/06/1994 | CN1088926A Novel compounds |
07/06/1994 | CN1025333C Method for preparing solvates of beta-lactam antibiotic |
07/06/1994 | CN1025332C Method for preparing thiochroman esters of phenols and terephthallates having retinoid-like activity |
07/05/1994 | US5326867 Antibiotics |
07/05/1994 | US5326858 Genetic engineering; antiarthritic agents |
07/05/1994 | US5326788 Inactivating viruses with aromatic polycyclic diones |
07/05/1994 | US5326782 Salts derived from 26-(dialkylaminoalkylsulphonyl)pristinamycin IIB |
07/05/1994 | US5326780 Acquired immunodeficiency syndrome |
07/05/1994 | US5326761 Suspension; sustained release |
07/05/1994 | US5326759 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
07/05/1994 | CA2112652A1 New transdominant tat variants for hiv virus |
07/05/1994 | CA1330531C Method of treating tinea pedis and related dermatophytic infections |
07/01/1994 | EP0612216A4 Phospholipid antimicrobial compositions. |
07/01/1994 | CA2106728A1 Phenoxy- and phenoxyalkyl-piperidines as anti- viral agents |
06/30/1994 | CA2605872A1 Intermediates for retroviral protease inhibiting compounds |
06/29/1994 | EP0604368A1 Anti retroviral hydrazine derivatives |
06/29/1994 | EP0604186A1 Inhibitors of HIV protease useful for the treatment of aids |
06/29/1994 | EP0604185A1 Inhibitors of HIV protease useful for the treatment of aids |